Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
19.96
-0.15 (-0.75%)
At close: Dec 5, 2025, 4:00 PM EST
19.70
-0.26 (-1.30%)
After-hours: Dec 5, 2025, 7:26 PM EST
Denali Therapeutics Employees
Denali Therapeutics had 422 employees as of December 31, 2024. The number of employees decreased by 23 or -5.17% compared to the previous year.
Employees
422
Change (1Y)
-23
Growth (1Y)
-5.17%
Revenue / Employee
n/a
Profits / Employee
-$1,181,858
Market Cap
2.93B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DNLI News
- 1 day ago - Denali Therapeutics Inc. (DNLI) Analyst/Investor Day Transcript - Seeking Alpha
- 2 days ago - Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement - GlobeNewsWire
- 4 days ago - Denali: Regulatory Delay Is A Strategic Opportunity - Seeking Alpha
- 14 days ago - Denali Therapeutics Inc. (DNLI) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - FDA Delays Decision Date For Denali Therapeutics' Lead Drug Candidate - Benzinga
- 7 weeks ago - Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) - GlobeNewsWire
- 3 months ago - Denali Therapeutics Inc. (DNLI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha